The Biology of Communication: How TYK2 Works

While many immune conditions are caused by “missing” cells, TYK2 deficiency is a problem with communication ^[1]. The immune cells are present, but they are “hard of hearing”—they cannot properly receive the signals that tell them to fight off specific germs ^[2].

To understand this, it helps to think of the TYK2 protein as an essential component of a radio receiver inside the cell ^[3]. When a signal (a cytokine) lands on the outside of the cell, TYK2 helps translate that signal into action ^[4].

The Broken Communication Pathways

In TYK2 deficiency, three main “radio stations” are affected, each responsible for a different part of defense:

1. IL-12 and IL-23 Pathways: The IL-12 signal normally tells the body to produce Interferon-gamma (IFN-γ) ^[5]. IFN-γ is the “master key” for killing mycobacteria (like the germs in the BCG vaccine or TB) ^[1]. Because TYK2 is broken, the body doesn’t produce enough IFN-γ when it needs it ^[6]. The IL-23 pathway is also disrupted, which further impairs specific immune responses, though this doesn’t always lead to the severe fungal infections seen in other IL-23 related diseases ^[7].
2. Type I Interferon (IFN-α/β) Pathway: This is the body’s main viral alarm system ^[8]. TYK2 is needed to relay this signal; without it, cells may not react quickly enough to stop a virus from spreading ^[2].
3. IL-10 Pathway: This signal usually tells the immune system to regulate inflammation ^[1]. In some cases, impaired IL-10 signaling may contribute to skin inflammation or eczema, though this is highly variable among patients ^[9].

A Crucial Distinction: The IFN-gamma Response

There is a broad group of conditions called MSMD (Mendelian Susceptibility to Mycobacterial Disease) that all cause vulnerability to mycobacteria ^[10]. MSMD includes defects in producing cytokines, the receptors that catch them, and downstream signaling.

In many other types of MSMD (like IFN-gamma receptor defects), the cells are unable to respond to IFN-gamma ^[10]. However, in TYK2 deficiency, the cells can still respond normally to IFN-gamma if it is provided to them ^[1][5]. The problem is simply that the body cannot make its own IFN-gamma effectively ^[5]. This preserved response is a vital clue that doctors use in specialized labs to help tell TYK2 deficiency apart from certain other MSMD conditions ^[11].

Confirming the Diagnosis

Because this condition is so rare, diagnosis often requires a combination of high-tech genetic “blueprints” and, sometimes, functional “stress tests” of the immune system.

• Genetic Testing: Doctors may use a targeted gene panel, Whole Exome Sequencing (WES), or Whole Genome Sequencing (WGS) ^[12]. To have the disease, a patient must have biallelic mutations—meaning two broken copies of the TYK2 gene (one from each parent) ^[13][6].
• Functional Assays: Since some genetic changes are harmless, doctors at expert centers sometimes perform cytokine stimulation assays to prove the mutation is causing a problem ^[12]. In a lab, scientists take a blood sample and “poke” the cells with signals like IL-12 or IFN-alpha to see if the cells react ^[9][5].

Reviewing Your Diagnostic Report

When you look at your medical reports, your specialist may use some or all of the following tests to confirm the diagnosis. Do not panic if a specific functional test is missing—not all labs have the capability to perform them, and a clinical geneticist can help interpret your specific results:

• Specific Variants: The report should list the exact location of the mutations (using codes like c. and p. nomenclature) ^[12][6].
• Zygosity and Phase: It should state the patient is “homozygous” (two identical mutations) or “compound heterozygous” (two different mutations) ^[13][12]. Often, testing parents confirms these are “in trans” (one from each parent) ^[13].
• Protein Levels: The report may note if the TYK2 protein is absent, reduced, or present but non-functional (though protein testing isn’t always available) ^[5][14].
• Functional Proof: If performed, a summary showing how the cells responded (or failed to respond) to IL-23 or Type I Interferons during lab testing ^[12][5].